Benzinga | Nov 15, 2021 10:48AM EST

AcelRx Pharmaceuticals Q3 EPS $(0.07), Sales $1.90M, Both Inline

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 30 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.90 million which met the analyst consensus estimate. This is a 38.89 percent increase over sales of $1.37 million the same period last year.